Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of Goods Sold (COGS) | $0.0 | $0.0 | $1,490.0K | $576.0K | $0.0 | $0.0 | $0.0 | $0.0 | $21.4M | $29.6M | $33.5M | $1,982.0K | $2,438.0K | $2,901.0K | $2,423.0K | $24.2M | $39.9M | $44.2M | $55.1M | $65.6M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Cost of Goods Sold (COGS) is $88.3M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Cost of Goods Sold (COGS) growth was 34.6%. The average annual Cost of Goods Sold (COGS) growth rates for Insmed Incorporated have been 27.9% over the past three years, 29.5% over the past five years.
Over the last year, Insmed Incorporated's Cost of Goods Sold (COGS) growth was 34.6%, which is higher than industry growth of (0.2%). It indicates that Insmed Incorporated's Cost of Goods Sold (COGS) growth is Good.